Meng SY - Search Results

1

[Drug resistance mechanism of non small cell lung cancer PC9/AB2 cell line with acquired drug resistance to gefitinib].

Ju LX, Zhou CC, Tang L, Zhao YM, Yang XJ, Su B, Meng SY, Li W, Yan LH, Ding YM. Ju LX, et al. Among authors: meng sy. Zhonghua Jie He He Hu Xi Za Zhi. 2010 May;33(5):354-8. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 20646614 Chinese.

2

Integrin-targeted paclitaxel nanoliposomes for tumor therapy.

Meng S, Su B, Li W, Ding Y, Tang L, Zhou W, Song Y, Caicun Z. Meng S, et al. Med Oncol. 2011 Dec;28(4):1180-7. doi: 10.1007/s12032-010-9621-1. Epub 2010 Jul 20. Med Oncol. 2011. PMID: 20645030

3

Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes.

Meng S, Su B, Li W, Ding Y, Tang L, Zhou W, Song Y, Li H, Zhou C. Meng S, et al. Nanotechnology. 2010 Oct 15;21(41):415103. doi: 10.1088/0957-4484/21/41/415103. Epub 2010 Sep 17. Nanotechnology. 2010. PMID: 20852356

4

RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies.

Li W, Su B, Meng S, Ju L, Yan L, Ding Y, Song Y, Zhou W, Li H, Tang L, Zhao Y, Zhou C. Li W, et al. Eur J Radiol. 2011 Nov;80(2):598-606. doi: 10.1016/j.ejrad.2011.01.051. Epub 2011 Feb 12. Eur J Radiol. 2011. PMID: 21316892

5

Magnetic resonance imaging contrast agent: cRGD-ferric oxide nanometer particle and its role in the diagnosis of tumor.

Yi X, Ding Y, Zeng Y, Zhou C, Luo B, Meng S, Rui W, Zhao Y, Li W. Yi X, et al. J Nanosci Nanotechnol. 2011 May;11(5):3800-7. doi: 10.1166/jnn.2011.3861. J Nanosci Nanotechnol. 2011. PMID: 21780371

6

Treatment and prognostic analysis of patients with leptomeningeal metastases from non-small cell lung cancer.

Xu Q, Chen X, Qian D, Wang Y, Meng S, Liu H, Zhou C. Xu Q, et al. Thorac Cancer. 2015 Jul;6(4):407-12. doi: 10.1111/1759-7714.12188. Epub 2015 Jul 2. Thorac Cancer. 2015. PMID: 26273394 Free PMC article.

7

Knockdown of Long Noncoding RNA ENST457720 Inhibits Proliferation of Non-Small Cell Lung Cancer Cells In Vitro and In Vivo.

Yu J, Fang Q, Meng S. Yu J, et al. Oncol Res. 2018 Dec 27;27(1):47-53. doi: 10.3727/096504018X15193843443255. Epub 2018 Mar 1. Oncol Res. 2018. PMID: 29495976 Free PMC article.

8

Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.

Meng S, Wang G, Lu Y, Fan Z. Meng S, et al. Lung Cancer. 2018 Jul;121:82-90. doi: 10.1016/j.lungcan.2018.04.024. Epub 2018 May 1. Lung Cancer. 2018. PMID: 29858032 Free PMC article.

9

Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging.

Song Y, Li W, Meng S, Zhou W, Su B, Tang L, Zhao Y, Wu X, Yin D, Fan M, Zhou C. Song Y, et al. Nanoscale Res Lett. 2018 Nov 27;13(1):380. doi: 10.1186/s11671-018-2797-6. Nanoscale Res Lett. 2018. PMID: 30483904 Free PMC article.

10

First-line continual EGFR-TKI plus local ablative therapy demonstrated survival benefit in EGFR-mutant NSCLC patients with oligoprogressive disease.

Xu Q, Liu H, Meng S, Jiang T, Li X, Liang S, Ren S, Zhou C. Xu Q, et al. J Cancer. 2019 Jan 1;10(2):522-529. doi: 10.7150/jca.26494. eCollection 2019. J Cancer. 2019. PMID: 30719148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters